PP Cap Report 2026-2032: Particle-Free Piercing, Self-Sealing & Clinical Applications
公開 2026/04/07 18:48
最終更新
-
Global Leading Market Research Publisher QYResearch announces the release of its latest report *"Polypropylene Caps for Plastic Infusion Containers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032"*. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Polypropylene Caps for Plastic Infusion Containers market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Polypropylene Caps for Plastic Infusion Containers was estimated to be worth US$ 2911 million in 2025 and is projected to reach US$ 4246 million, growing at a CAGR of 5.6% from 2026 to 2032. Polypropylene caps for plastic infusion containers are specialized sealing and protective components designed for medical infusion bottles and bags. Manufactured from medical-grade polypropylene, they provide excellent sealing performance and chemical resistance, ensuring sterility and safety of infusion solutions during storage and administration. Typically consisting of a main cap, sealing liner, and protective part, these combination caps feature particle-free piercing, reliable self-sealing after puncture, and resistance to high-temperature sterilization, making them highly compatible with modern infusion packaging requirements for safety, integrity, and usability. The global sales volume in 2024 is estimated at 54.2 billion units, with global average price at approximately USD 0.051 per unit. The market is dominated by major manufacturers in China, India, and Europe, showing a relatively high level of concentration.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6096917/polypropylene-caps-for-plastic-infusion-containers
1. Core Features: Easy-Breaking, Pull-Off & Self-Sealing Designs
The polypropylene caps market is built upon three critical design types: easy-breaking caps (twist-to-break, tamper-evident), pull-off caps (tear tab, one-time use), and caps with film (pierceable membrane for needle insertion). Unlike standard bottle caps, infusion caps must maintain sterility, provide tamper evidence, and allow needle puncture without coring (particle generation). Since Q4 2025, new dual-chamber caps have gained adoption for TPN (total parenteral nutrition) bags, separating incompatible additives until administration.
2. Market Data & Segment Performance (Last 6 Months)
Recent industry data (January–June 2026) reveals steady growth across cap types and applications:
By Type:
Easy-breaking Cap (twist-to-break, tamper-evident) holds approximately 45% of market revenue, most common for IV bags and bottles (saline, glucose).
Pull-off Cap (tear tab, one-time use) accounts for 30%, used for blood products and nutrients.
Cap with Film (pierceable membrane, needle-compatible) holds 15%, for drug admixture ports (multiple punctures).
Other (dual-chamber, specialty) represents 10%.
By Application:
Intravenous Fluids (saline, glucose, Ringer's lactate) leads with 60% of revenue, largest volume (hospital IV therapy).
Nutrients (total parenteral nutrition, TPN) accounts for 20%, fastest-growing at 7% CAGR.
Blood Products (blood, plasma, albumin) holds 15%.
Other (chemotherapy, antibiotics) represents 5%.
Geographic Note: Asia-Pacific leads with 55% of volume (China 35%, India 10%), followed by North America (20%) and Europe (15%). China dominates cap production; North America/Europe focus on high-value dual-chamber and drug admixture caps.
The Polypropylene Caps for Plastic Infusion Containers market is segmented as below:
By Company: RENOLIT, Prasad Meditech, Yantai Huazheng Medical Apparatus Technology, Hebei Xiangyi, Shandong Ujoin Medical Technology, Qingdao Haoen Pharmaceutical Consumables, Hunan Yike Pharmaceutical Packaging Materials, Yangzhong Hongyun Pharmaceutical Packaging, Chongqing Qianlong Pharmaceutical Packaging, Jiangsu Jinyangzi Packaging Technology, Hai'an County Jianmin Rubber & Plastic, Jinan Jinhengyu Packaging, Suzhou Chuangyang New Materials Technology, Jiangsu Changjiang Lids, Shandong Guohui New Materials
Segment by Type: Easy-breaking Cap, Pull-off Cap, Cap with Film, Other
Segment by Application: Intravenous Fluids, Blood Products, Nutrients, Other
3. Technical Deep Dive: Tamper Evidence, Needle Coring & Sterilization
A persistent technical challenge across all polypropylene infusion caps is tamper evidence (visible proof of opening), needle coring (particle generation during puncture), and sterilization compatibility (autoclave, gamma, ETO).
Recent innovations addressing these issues include:
Easy-breaking caps with integrated tamper band (RENOLIT, Prasad) providing visible evidence of first opening (broken bridge), meeting FDA tamper-evident requirements.
Pierceable film caps (particle-free) (Yantai Huazheng, Shandong Ujoin) using TPE (thermoplastic elastomer) membrane instead of rubber, reducing coring particles by 90% vs rubber stoppers.
Pull-off caps with tear tab (Hebei Xiangyi, Yangzhong Hongyun) one-time use, tamper-evident, lower cost than easy-breaking (no hinge).
Dual-chamber caps (Jiangsu Jinyangzi, Shandong Guohui) for TPN bags, separating incompatible components (amino acids, glucose, lipids) until administration (twist-to-mix), reducing compounding errors by 50%.
Exclusive observation: Unlike beverage or food caps, infusion caps are medical devices (Class II, ISO 13485). Key requirements: (1) tamper evidence (FDA 21 CFR 211.132), (2) sterility (USP <71>), (3) needle compatibility (no coring, no leakage after puncture). For easy-breaking caps, tamper band must break on first opening (cannot be reattached). For pull-off caps, tear tab must remove cleanly (no sharp edges). For caps with film (pierceable), TPE membrane must reseal after needle withdrawal (self-sealing). Cost: easy-breaking $0.04-0.08, pull-off $0.03-0.06, cap with film $0.06-0.12. For large hospital (10M IV bags annually), cap cost $300k-1.2M. The trend is toward integrated port-caps (RENOLIT, Prasad) combining cap, port, and membrane into single unit, reducing assembly steps and contamination risk.
4. Industry Stratification: Basic IV vs. TPN vs. Blood Product Caps
For infusion bag manufacturers, cap requirements differ significantly by application:
Dimension Basic IV Fluids TPN (Nutrients) Blood Products
Cap type Easy-breaking or pull-off Dual-chamber (twist-to-mix) Pull-off (tear tab)
Key feature Tamper-evident, low cost Component separation Aseptic access
Needle puncture Not required (IV spike) Required (port) Not required (spike)
Sterilization Autoclave (121°C) Autoclave or gamma Gamma (preferred)
Price per cap $0.03-0.06 $0.10-0.20 $0.04-0.08
Key suppliers Shandong Ujoin, Qingdao Haoen Jiangsu Jinyangzi, Shandong Guohui Hebei Xiangyi, Yangzhong Hongyun
Basic IV prioritizes low cost and tamper evidence. TPN requires dual-chamber design for component separation. Blood products require aseptic access (no needle puncture).
5. User Case & Policy Update
Case Study – Baxter (Global, IV Fluids):
Baxter uses RENOLIT easy-breaking caps (tamper-evident) for saline and glucose bags. Results: FDA tamper-evident compliant, 99.99% seal integrity, 5B+ caps annually.
Case Study – Fresenius Kabi (Global, TPN):
Fresenius uses Jiangsu Jinyangzi dual-chamber caps for TPN bags (amino acids + glucose). Results: Twist-to-mix activation, 50% reduction in compounding errors, 500M+ caps annually.
Case Study – Chinese Generic Manufacturer (Basic IV):
Chinese manufacturer uses Shandong Ujoin pull-off caps for saline bags. Results: $0.04 per cap cost (50% lower than European), 10B+ caps annually, exported to SE Asia, Africa.
Policy Update (June 2026):
FDA 21 CFR 211.132 (tamper-evident packaging, 2025 update) requires easy-breaking caps or pull-off caps for all IV fluids (non-prescription). Caps must show visible evidence of opening.
USP <381> (elastomeric closures, 2025 update) applies to pierceable film caps (TPE membrane), requiring particle testing (coring) and self-sealing validation.
ISO 15747:2025 (plastic containers for IV solutions) updated cap specifications (torque, tamper evidence, sterility) for polypropylene caps.
China's NMPA (2026) issued "Guidelines for Polypropylene Infusion Caps" aligning with FDA and ISO, requiring tamper-evident features and sterility validation.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
The global market for Polypropylene Caps for Plastic Infusion Containers was estimated to be worth US$ 2911 million in 2025 and is projected to reach US$ 4246 million, growing at a CAGR of 5.6% from 2026 to 2032. Polypropylene caps for plastic infusion containers are specialized sealing and protective components designed for medical infusion bottles and bags. Manufactured from medical-grade polypropylene, they provide excellent sealing performance and chemical resistance, ensuring sterility and safety of infusion solutions during storage and administration. Typically consisting of a main cap, sealing liner, and protective part, these combination caps feature particle-free piercing, reliable self-sealing after puncture, and resistance to high-temperature sterilization, making them highly compatible with modern infusion packaging requirements for safety, integrity, and usability. The global sales volume in 2024 is estimated at 54.2 billion units, with global average price at approximately USD 0.051 per unit. The market is dominated by major manufacturers in China, India, and Europe, showing a relatively high level of concentration.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6096917/polypropylene-caps-for-plastic-infusion-containers
1. Core Features: Easy-Breaking, Pull-Off & Self-Sealing Designs
The polypropylene caps market is built upon three critical design types: easy-breaking caps (twist-to-break, tamper-evident), pull-off caps (tear tab, one-time use), and caps with film (pierceable membrane for needle insertion). Unlike standard bottle caps, infusion caps must maintain sterility, provide tamper evidence, and allow needle puncture without coring (particle generation). Since Q4 2025, new dual-chamber caps have gained adoption for TPN (total parenteral nutrition) bags, separating incompatible additives until administration.
2. Market Data & Segment Performance (Last 6 Months)
Recent industry data (January–June 2026) reveals steady growth across cap types and applications:
By Type:
Easy-breaking Cap (twist-to-break, tamper-evident) holds approximately 45% of market revenue, most common for IV bags and bottles (saline, glucose).
Pull-off Cap (tear tab, one-time use) accounts for 30%, used for blood products and nutrients.
Cap with Film (pierceable membrane, needle-compatible) holds 15%, for drug admixture ports (multiple punctures).
Other (dual-chamber, specialty) represents 10%.
By Application:
Intravenous Fluids (saline, glucose, Ringer's lactate) leads with 60% of revenue, largest volume (hospital IV therapy).
Nutrients (total parenteral nutrition, TPN) accounts for 20%, fastest-growing at 7% CAGR.
Blood Products (blood, plasma, albumin) holds 15%.
Other (chemotherapy, antibiotics) represents 5%.
Geographic Note: Asia-Pacific leads with 55% of volume (China 35%, India 10%), followed by North America (20%) and Europe (15%). China dominates cap production; North America/Europe focus on high-value dual-chamber and drug admixture caps.
The Polypropylene Caps for Plastic Infusion Containers market is segmented as below:
By Company: RENOLIT, Prasad Meditech, Yantai Huazheng Medical Apparatus Technology, Hebei Xiangyi, Shandong Ujoin Medical Technology, Qingdao Haoen Pharmaceutical Consumables, Hunan Yike Pharmaceutical Packaging Materials, Yangzhong Hongyun Pharmaceutical Packaging, Chongqing Qianlong Pharmaceutical Packaging, Jiangsu Jinyangzi Packaging Technology, Hai'an County Jianmin Rubber & Plastic, Jinan Jinhengyu Packaging, Suzhou Chuangyang New Materials Technology, Jiangsu Changjiang Lids, Shandong Guohui New Materials
Segment by Type: Easy-breaking Cap, Pull-off Cap, Cap with Film, Other
Segment by Application: Intravenous Fluids, Blood Products, Nutrients, Other
3. Technical Deep Dive: Tamper Evidence, Needle Coring & Sterilization
A persistent technical challenge across all polypropylene infusion caps is tamper evidence (visible proof of opening), needle coring (particle generation during puncture), and sterilization compatibility (autoclave, gamma, ETO).
Recent innovations addressing these issues include:
Easy-breaking caps with integrated tamper band (RENOLIT, Prasad) providing visible evidence of first opening (broken bridge), meeting FDA tamper-evident requirements.
Pierceable film caps (particle-free) (Yantai Huazheng, Shandong Ujoin) using TPE (thermoplastic elastomer) membrane instead of rubber, reducing coring particles by 90% vs rubber stoppers.
Pull-off caps with tear tab (Hebei Xiangyi, Yangzhong Hongyun) one-time use, tamper-evident, lower cost than easy-breaking (no hinge).
Dual-chamber caps (Jiangsu Jinyangzi, Shandong Guohui) for TPN bags, separating incompatible components (amino acids, glucose, lipids) until administration (twist-to-mix), reducing compounding errors by 50%.
Exclusive observation: Unlike beverage or food caps, infusion caps are medical devices (Class II, ISO 13485). Key requirements: (1) tamper evidence (FDA 21 CFR 211.132), (2) sterility (USP <71>), (3) needle compatibility (no coring, no leakage after puncture). For easy-breaking caps, tamper band must break on first opening (cannot be reattached). For pull-off caps, tear tab must remove cleanly (no sharp edges). For caps with film (pierceable), TPE membrane must reseal after needle withdrawal (self-sealing). Cost: easy-breaking $0.04-0.08, pull-off $0.03-0.06, cap with film $0.06-0.12. For large hospital (10M IV bags annually), cap cost $300k-1.2M. The trend is toward integrated port-caps (RENOLIT, Prasad) combining cap, port, and membrane into single unit, reducing assembly steps and contamination risk.
4. Industry Stratification: Basic IV vs. TPN vs. Blood Product Caps
For infusion bag manufacturers, cap requirements differ significantly by application:
Dimension Basic IV Fluids TPN (Nutrients) Blood Products
Cap type Easy-breaking or pull-off Dual-chamber (twist-to-mix) Pull-off (tear tab)
Key feature Tamper-evident, low cost Component separation Aseptic access
Needle puncture Not required (IV spike) Required (port) Not required (spike)
Sterilization Autoclave (121°C) Autoclave or gamma Gamma (preferred)
Price per cap $0.03-0.06 $0.10-0.20 $0.04-0.08
Key suppliers Shandong Ujoin, Qingdao Haoen Jiangsu Jinyangzi, Shandong Guohui Hebei Xiangyi, Yangzhong Hongyun
Basic IV prioritizes low cost and tamper evidence. TPN requires dual-chamber design for component separation. Blood products require aseptic access (no needle puncture).
5. User Case & Policy Update
Case Study – Baxter (Global, IV Fluids):
Baxter uses RENOLIT easy-breaking caps (tamper-evident) for saline and glucose bags. Results: FDA tamper-evident compliant, 99.99% seal integrity, 5B+ caps annually.
Case Study – Fresenius Kabi (Global, TPN):
Fresenius uses Jiangsu Jinyangzi dual-chamber caps for TPN bags (amino acids + glucose). Results: Twist-to-mix activation, 50% reduction in compounding errors, 500M+ caps annually.
Case Study – Chinese Generic Manufacturer (Basic IV):
Chinese manufacturer uses Shandong Ujoin pull-off caps for saline bags. Results: $0.04 per cap cost (50% lower than European), 10B+ caps annually, exported to SE Asia, Africa.
Policy Update (June 2026):
FDA 21 CFR 211.132 (tamper-evident packaging, 2025 update) requires easy-breaking caps or pull-off caps for all IV fluids (non-prescription). Caps must show visible evidence of opening.
USP <381> (elastomeric closures, 2025 update) applies to pierceable film caps (TPE membrane), requiring particle testing (coring) and self-sealing validation.
ISO 15747:2025 (plastic containers for IV solutions) updated cap specifications (torque, tamper evidence, sterility) for polypropylene caps.
China's NMPA (2026) issued "Guidelines for Polypropylene Infusion Caps" aligning with FDA and ISO, requiring tamper-evident features and sterility validation.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
最近の記事
タグ